Globeflex Capital L P Takes Position in Guardian Pharmacy Services, Inc. $GRDN

Key Points

• Globeflex Capital initiated a position in Guardian Pharmacy Services during the second quarter, buying 44,354 shares valued at approximately $1.86 million, or about 0.09% of the company.
• Guardian reported quarterly earnings of $0.29 per share, beating estimates by $0.03, while revenue reached $351.77 million versus the $340.45 million consensus forecast.
• Analyst sentiment remains favorable, with eight Buy ratings and one Hold rating; the consensus price target is $43.83 compared with the stock’s reported price of $37.58.

Globeflex Capital L P bought a new stake in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 44,354 shares of the company's stock, valued at approximately $1,857,000. Globeflex Capital L P owned approximately 0.09% of Guardian Pharmacy Services as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently bought and sold shares of the company. Ameritas Investment Partners Inc. increased its stake in Guardian Pharmacy Services by 26.5% in the 3rd quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company's stock worth $43,000 after buying an additional 345 shares in the last quarter. Raymond James Financial Inc. purchased a new position in shares of Guardian Pharmacy Services in the second quarter valued at about $43,000. Strs Ohio bought a new position in shares of Guardian Pharmacy Services in the fourth quarter worth about $75,000. Clearstead Advisors LLC boosted its stake in shares of Guardian Pharmacy Services by 196.3% in the fourth quarter. Clearstead Advisors LLC now owns 2,628 shares of the company's stock worth $79,000 after acquiring an additional 1,741 shares during the period. Finally, State of Wyoming purchased a new stake in shares of Guardian Pharmacy Services during the second quarter worth about $58,000.

Guardian Pharmacy Services Stock Performance

Shares of Guardian Pharmacy Services stock opened at $37.58 on Tuesday. The stock has a market cap of $1.87 billion, a price-to-earnings ratio of 36.48, a price-to-earnings-growth ratio of 1.96 and a beta of 0.11. The stock has a 50 day moving average price of $40.33 and a 200-day moving average price of $37.79. Guardian Pharmacy Services, Inc. has a one year low of $23.14 and a one year high of $47.02.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported $0.29 earnings per share for the quarter, beating the consensus estimate of $0.26 by $0.03. Guardian Pharmacy Services had a net margin of 4.50% and a return on equity of 29.97%. The business had revenue of $351.77 million for the quarter, compared to the consensus estimate of $340.45 million. Sell-side analysts predict that Guardian Pharmacy Services, Inc. will post 1.19 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

GRDN has been the subject of a number of research analyst reports. Zacks Research lowered shares of Guardian Pharmacy Services from a "strong-buy" rating to a "hold" rating in a report on Monday, May 11th. Bank of America boosted their target price on shares of Guardian Pharmacy Services from $42.00 to $47.00 and gave the stock a "buy" rating in a report on Wednesday, June 17th. Weiss Ratings upgraded shares of Guardian Pharmacy Services from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Thursday. Oppenheimer lifted their price target on shares of Guardian Pharmacy Services from $43.00 to $49.00 and gave the company an "outperform" rating in a report on Friday, August 7th. Finally, Truist Financial boosted their price target on shares of Guardian Pharmacy Services from $43.00 to $47.00 and gave the stock a "buy" rating in a research note on Wednesday, June 17th. Eight analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, Guardian Pharmacy Services has an average rating of "Moderate Buy" and a consensus target price of $43.83.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source